Pharma > Nova Content

(Reuters) - U.S. health regulators approved on Friday the stroke preventer Xarelto from Bayer AG and Johnson & Johnson for people with a common heart rhythm... Read More »

  ASLAN Pharmaceuticals and Bristol-Myers Squibb announced today that they have engaged in a partnership for the rapid development and distribution of the... Read More »

LONDON (Reuters) - GlaxoSmithKline Plc has agreed in principle to settle several long-standing disputes with the U.S. government over the way it marketed and... Read More »

LONDON (Reuters) - Britain's highest court upheld a patent on Wednesday on a gene sequence held by Human Genome Sciences related to its new lupus drug Benlysta... Read More »

  On August 25, 2011 Johnson & Johnson Pharmaceutical Research and Development, L.L.C (J&JPRD) received approval from the US Food and Drug... Read More »

CHICAGO (Reuters) - Stimulants used to treat attention deficit hyperactivity disorder do not increase the risk of heart attacks, strokes or sudden death, U.S... Read More »

Traditionally, drugs were discovered by identifying active ingredients in known remedies or through serendipitous discovery, such as penicillin. Currently, drug... Read More »

  By Toni Clarke               (Reuters) - Biogen Idec Inc's said on Wednesday its experimental... Read More »

  Bristol-Myers Squibb is combining its protease inhibitor Reyataz (atazanavir sulfate) with a pharmacoenhancing agent from Gilead Sciences Inc. called... Read More »

  By Lewis Krauskopf and Ransdell Pierson               (Reuters) - Eli Lilly and Co withdrew its sepsis drug... Read More »

  LONDON (Reuters) - Two lung drugs being developed by Novartis and its British partner Vectura face delays in the United States, the... Read More »

  (Reuters) - Smokers who take Pfizer's pill Chantix to help them quit do not have a higher risk of being hospitalized for psychiatric events such as... Read More »

  (Reuters) - AtriCure Inc's Synergy Ablation System heart-rhythm device is safe and effective, but its trial size and design raise some concerns, U.S... Read More »